Cardiopulmonary Disease Diagnostics and Treatment Market Research Report Information By Disease Type (Cardiovascular and Respiratory Diseases), By Type (Diagnosis-Electrocardiogram and Treatment -Medication), By End-Users (Diagnostic Centers and Hospitals), and By Region (North America, Europe, Asia-Pacific, And Rest Of The World) –Market Forecast Till 2032

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Cardiopulmonary Disease Diagnostics and Treatment Market, by Disease Type

6.1 Introduction

6.2 Cardiovascular diseases

6.2.1 Coronary artery disease

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

6.2.2 Angina pectoris

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

6.2.3 Myocardial infraction

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

6.2.4 Dysrhythmia

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

6.2.5 Hypertension

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

6.2.6 Others

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

6.3 Respiratory diseases

6.3.1 Influenza

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

6.3.2 Asthma

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

6.3.3 Bronchitis

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

6.3.4 Emphysema

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

6.3.5 Cystic fibrosis

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

6.3.6 Others

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

Chapter 7. Global Cardiopulmonary Disease Diagnostics and Treatment Market, by Type

7.1 Introduction

7.2 Diagnostics

7.2.1 Electrocardiogram (ECG)

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

7.2.2 Holter monitoring

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

7.2.3 Echocardiogram

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

7.2.4 Stress test

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

7.2.5 Cardiac catheterization

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

7.2.6 Cardiac computerized tomography (CT) scan

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

7.2.7 Cardiac magnetic resonance imaging (MRI)

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

7.2.8 Single-photon emission computed tomography (SPECT)

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

7.2.9 Stress blood pressure monitors

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

7.2.10 Pulse oximeters

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

7.2.10 Spirometry

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

7.3 Treatment

7.3.1 Medication

7.3.1.1 Angiotensin-converting enzyme (ACE) inhibitors

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

7.3.1.2 Angiotensin II receptor blockers (ARBS)

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

7.3.1.3 Anticoagulants

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

7.3.1.4 Antiplatelet agents

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

7.3.1.5 Others

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

Chapter 8. Global Cardiopulmonary Disease Diagnostics and Treatment Market, by End-Users

8.1 Introduction

8.2 Hospitals

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

8.3 Clinics

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

8.4 Diagnostic centers

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

8.5 Specialty Clinics and Rehab Centers

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

8.6 Research Institutes

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

8.7 Others

Market Estimates & Forecast, by Region, 2023-2032

Market Estimates & Forecast, by Country, 2023-2032

Chapter 9. Global Cardiopulmonary Disease Diagnostics and Treatment, by Region

9.1 Introduction

9.2 Americas

9.2.1 North America

9.2.1.1 US

9.2.1.2 Canada

9.2.2 South America

9.3 Europe

9.3.1 Western Europe

9.3.1.1 Germany

9.3.1.2 France

9.3.1.3 Italy

9.3.1.4 Spain

9.3.1.5 UK

9.3.1.6 Rest of Western Europe

9.3.2 Eastern Europe

9.4 Asia-Pacific

9.4.1 Japan

9.4.2 China

9.4.3 India

9.4.4 Australia

9.4.5 South Korea

9.4.6 Rest of Asia-Pacific

9.5 Middle East & Africa

9.5.1 Middle East

9.5.2 Africa

Chapter 10. Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

Chapter 11. Company Profiles

11.1 Cardinal Health

11.1.1 Company Overview

11.1.2 Type Overview

11.1.3 Financials Overview

11.1.4 Key Developments

11.1.5 SWOT Analysis

11.2 Cosmed Medical

11.2.1 Company Overview

11.2.2 Type Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 GE Healthcare

11.3.1 Company Overview

11.3.2 Type Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 Halma plc.

11.4.1 Company Overview

11.4.2 Technology/Business Segment Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 Hill-Rom Holdings, Inc.

11.5.1 Company Overview

11.5.2 Type Overview

11.5.3 Financial overview

11.5.4 Key Developments

11.5.5 SWOT Analysis

11.6 Koninklijke Philips N.V.

11.6.1 Company Overview

11.6.2 Type Overview

11.6.3 Financial Overview

11.6.4 Key Developments

11.6.5 SWOT Analysis

11.7 MGC Diagnostics Corporation

11.7.1 Overview

11.7.2 Type Overview

11.7.3 Financial Overview

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.8 NIHON KOHDEN CORPORATION

11.8.1 Overview

11.8.2 Type/ Technology Overview

11.8.3 Financials

11.8.4 Key Developments

11.8.5 SWOT Analysis

11.9 Schiller AG

11.9.1 Overview

11.9.2 Type Overview

11.9.3 Financials

11.9.4 Key Developments

11.9.5 SWOT Analysis

11.9 Masimo Corporation

11.9.1 Overview

11.9.2 Type Overview

11.9.3 Financials

11.9.4 Key Developments

11.9.5 SWOT Analysis

11.11 Vyaire Medical Inc.

11.11.1 Overview

11.11.2 Type Overview

11.11.3 Financials

11.11.4 Key Developments

11.11.5 SWOT Analysis

Chapter 12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s Viewpoint

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Predictions for the Cardiopulmonary Disease Diagnostics and Treatment Industry

Chapter 13. Appendix

LIST OF TABLES

Table 1 Global Cardiopulmonary Disease Diagnostics and Treatment Market Synopsis, 2023-2032

Table 2 Global Cardiopulmonary Disease Diagnostics and Treatment Market Estimates and Forecast, 2023-2032 (USD Million)

Table 3 Global Cardiopulmonary Disease Diagnostics and Treatment Market, by Region, 2023-2032 (USD Million)

Table 4 Global Cardiopulmonary Disease Diagnostics and Treatment Market, by Type, 2023-2032 (USD Million)

Table 5 Global Cardiopulmonary Disease Diagnostics and Treatment Market, by Disease type, 2023-2032 (USD Million)

Table 6 Global Cardiopulmonary Disease Diagnostics and Treatment Market, by End-users, 2023-2032 (USD Million)

Table 7 North America: Cardiopulmonary Disease Diagnostics and Treatment Market, by Type, 2023-2032 (USD

Million)

Table 8 North America: Cardiopulmonary Disease Diagnostics and Treatment Market, by Disease type, 2023-2032 (USD

Million)

Table 9 North America: Cardiopulmonary Disease Diagnostics and Treatment Market, by End-users, 2023-2032 (USD Million)

Table 10 US: Cardiopulmonary Disease Diagnostics and Treatment Market, by Type, 2023-2032 (USD Million)

Table 11 US: Cardiopulmonary Disease Diagnostics and Treatment Market, by Disease type, 2023-2032 (USD Million)

Table 12 US: Cardiopulmonary Disease Diagnostics and Treatment Market, by End-users, 2023-2032 (USD Million)

Table 13 Canada: Cardiopulmonary Disease Diagnostics and Treatment Market, by Type, 2023-2032 (USD Million)

Table 14 Canada: Cardiopulmonary Disease Diagnostics and Treatment Market, by Disease type, 2023-2032 (USD Million)

Table 15 Canada Cardiopulmonary Disease Diagnostics and Treatment Market, by End-users, 2023-2032 (USD Million)

Table 16 South America: Cardiopulmonary Disease Diagnostics and Treatment Market, by Type, 2023-2032 (USD

Million)

Table 17 South America: Cardiopulmonary Disease Diagnostics and Treatment Market, by Disease type, 2023-2032 (USD

Million)

Table 18 South America: Cardiopulmonary Disease Diagnostics and Treatment Market, by End-users, 2023-2032 (USD Million)

Table 19 Europe: Cardiopulmonary Disease Diagnostics and Treatment Market, by Type, 2023-2032 (USD Million)

Table 20 Europe: Cardiopulmonary Disease Diagnostics and Treatment Market, by Disease type, 2023-2032 (USD Million)

Table 21 Europe: Cardiopulmonary Disease Diagnostics and Treatment Market, by End-users, 2023-2032 (USD Million)

Table 22 Western Europe: Cardiopulmonary Disease Diagnostics and Treatment Market, by Type, 2023-2032 (USD

Million)

Table 23 Western Europe: Cardiopulmonary Disease Diagnostics and Treatment Market, by Disease type, 2023-2032 (USD

Million)

Table 24 Western Europe: Cardiopulmonary Disease Diagnostics and Treatment Market, by End-users, 2023-2032 (USD Million)

Table 25 Eastern Europe Cardiopulmonary Disease Diagnostics and Treatment Market, by Type, 2023-2032 (USD

Million)

Table 26 Eastern Europe: Cardiopulmonary Disease Diagnostics and Treatment Market, by Disease type, 2023-2032 (USD

Million)

Table 27 Eastern Europe: Cardiopulmonary Disease Diagnostics and Treatment Market, by End-users, 2023-2032 (USD Million)

Table 28 Asia-Pacific: Cardiopulmonary Disease Diagnostics and Treatment Market, by Type, 2023-2032 (USD

Million)

Table 29 Asia-Pacific: Cardiopulmonary Disease Diagnostics and Treatment Market, by Disease type, 2023-2032 (USD

Million)

Table 30 Asia-Pacific: Cardiopulmonary Disease Diagnostics and Treatment Market, by End-users, 2023-2032 (USD Million)

Table 31 Middle East & Africa: Cardiopulmonary Disease Diagnostics and Treatment Market, by Type, 2023-2032

(USD Million)

Table 32 Middle East & Africa: Cardiopulmonary Disease Diagnostics and Treatment Market, by Disease type, 2023-2032

(USD Million)

Table 33 Middle East & Africa Cardiopulmonary Disease Diagnostics and Treatment Market, by End-users, 2023-2032 (USD Million)

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Cardiopulmonary Disease Diagnostics and Treatment Market

Figure 3 Segmentation Market Dynamics for Global Cardiopulmonary Disease Diagnostics and Treatment Market

Figure 4 Global Cardiopulmonary Disease Diagnostics and Treatment Market Share, by Type, 2020

Figure 5 Global Cardiopulmonary Disease Diagnostics and Treatment Market Share, by Disease type, 2020

Figure 6 Global Cardiopulmonary Disease Diagnostics and Treatment Market, by End-users, 2023-2032 (USD Million)

Figure 7 Global Cardiopulmonary Disease Diagnostics and Treatment Market Share, by Region, 2020

Figure 8 North America: Cardiopulmonary Disease Diagnostics and Treatment Market Share, by Country, 2020

Figure 9 Europe: Cardiopulmonary Disease Diagnostics and Treatment Market Share, by Country, 2020

Figure 10 Asia-Pacific: Cardiopulmonary Disease Diagnostics and Treatment Market Share, by Country, 2020

Figure 11 Middle East & Africa: Cardiopulmonary Disease Diagnostics and Treatment Market Share, by Country, 2020

Figure 12 Global Cardiopulmonary Disease Diagnostics and Treatment Market: Company Share Analysis, 2020 (%)

Figure 13 Cardinal Health: Key Financials

Figure 14 Cardinal Health: Segmental Revenue

Figure 15 Cardinal Health: Geographical Revenue

Figure 16 Cosmed Medical: Key Financials

Figure 17 Cosmed Medical: Segmental Revenue

Figure 18 Cosmed Medical: Geographical Revenue

Figure 19 GE Healthcare: Key Financials

Figure 20 GE Healthcare: Segmental Revenue

Figure 21 GE Healthcare: Geographical Revenue

Figure 22 Halma plc: Key Financials

Figure 23 Halma plc: Segmental Revenue

Figure 24 Halma plc: Geographical Revenue

Figure 25 Hill-Rom Holdings, Inc.: Key Financials

Figure 26 Hill-Rom Holdings, Inc.: Segmental Revenue

Figure 27 Hill-Rom Holdings, Inc.: Geographical Revenue

Figure 28 Koninklijke Philips N.V.: Key Financials

Figure 29 Koninklijke Philips N.V: Segmental Revenue

Figure 30 Koninklijke Philips N.V.: Geographical Revenue

Figure 31 MGC Diagnostics Corporation: Key Financials

Figure 32 MGC Diagnostics Corporation: Segmental Revenue

Figure 33 MGC Diagnostics Corporation: Geographical Revenue

Figure 34 NIHON KOHDEN CORPORATION: Key Financials

Figure 35 NIHON KOHDEN CORPORATION: Segmental Revenue

Figure 36 NIHON KOHDEN CORPORATION: Geographical Revenue

Figure 37 Schiller AG: Key Financials

Figure 38 Schiller AG Segmental Revenue

Figure 39 Schiller AG: Geographical Revenue

Figure 40 Masimo Corporation: Key Financials

Figure 41 Masimo Corporation: Segmental Revenue

Figure 42 Masimo Corporation: Geographical Revenue

Figure 43 Vyaire Medical Inc.: Key Financials

Figure 44 Vyaire Medical Inc.: Segmental Revenue

Figure 45 Vyaire Medical Inc.: Geographical Revenue